Prostatitis and Prostate Cancer Development
Prostatitis and Prostate Cancer Development
批准号:
8462944
负责人:
Lawrence Fong
金额:
$38.92万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2017-06-30
关键词:
Acute ProstatitisAdenocarcinomaAffectAllelesAnimal ModelAntibody FormationAntigensAtypiaAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmunityBiological MarkersBiopsyCessation of lifeChronicChronic ProstatitisClinicalColorectalDataDevelopmentDiseaseEpitopesEtiologyFoundationsFrequenciesGeneticGenetic EngineeringGenetically Engineered MouseHumanImmuneImmune ToleranceImmune responseImmune systemImmunologicsInflammationInflammatoryKnockout MiceLarge T AntigenLungMalignant NeoplasmsMalignant neoplasm of prostateModelingMusNaturePTEN genePancreasPapillaryPatientsPelvic PainProstateProstaticProstatic Intraepithelial NeoplasiasProteinsRoleSelf ToleranceSeminal VesiclesSimian virus 40StomachT cell responseTestingThyroid GlandTissuesTo autoantigenTransgenic MiceWild Type MouseWorkautoreactivitychronic pelvic paindisease diagnosisinsightmenmouse modelnovelnovel strategiesprostate cancer modelprostate cancer preventionprostatitisrecombinasetumortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Prostatitis and prostate cancer are extremely common diseases in men, but the relationship between these two diseases is unknown. While acute prostatitis is thought to be infectious in nature, the etiology of chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS) and asymptomatic inflammatory prostatitis remains unclear. By studying Aire-deficient mice that have defective immune tolerance and develop spontaneous prostatitis, we have identified a novel prostate autoantigen. Moreover, we have found that CP/CPPS patients with biopsy-proven inflammation in their prostate glands possess immune responses to the analogous human protein, semenogelin (Sg). These results provide new evidence to support autoimmunity as a potential cause for chronic prostatitis. Moreover, by assessing for immune responses to Sg, we may be able to detect prostate inflammation in symptomatic or asymptomatic men. Animal models as well as clinical observations demonstrate that chronic inflammation can enhance the development or certain tumors. We hypothesize that chronic prostatitis contributes to prostate cancer development. The overall objectives of this proposal are to examine: 1) whether there is an association between an immune responses to the prostate autoantigen Sg and prostate cancer in humans; and 2) whether chronic inflammation can enhance the development of prostate cancer in mouse models. In specific aim 1, we will determine whether immune responses to Sg are associated with the presence of inflammation and/or prostate cancer in men undergoing prostate biopsy. In the specific aim 2, we will determine whether chronic prostatitis can alter the development of tumors in mouse models of prostate cancer. This proposal will provide insight in the role of chronic inflammation and prostate cancer development. Moreover, these results could provide a rationale for prostate cancer prevention by treating chronic prostatitis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determinants of response to cancer immunotherapy
-
批准号:10299968
-
项目类别:
-
资助金额:$81.55万
-
财政年份:2021
-
负责人:Lawrence Fong
-
依托单位:
Determinants of response to cancer immunotherapy
-
批准号:10458030
-
项目类别:
-
资助金额:$94.96万
-
财政年份:2021
-
负责人:Lawrence Fong
-
依托单位:
Determinants of response to cancer immunotherapy
-
批准号:10664918
-
项目类别:
-
资助金额:$94.96万
-
财政年份:2021
-
负责人:Lawrence Fong
-
依托单位:
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
-
批准号:10477950
-
项目类别:
-
资助金额:$84.5万
-
财政年份:2018
-
负责人:Lawrence Fong
-
依托单位:
Determinants of prostate cancer sensitivity to PD-1 blockade
-
批准号:9849129
-
项目类别:
-
资助金额:$36.83万
-
财政年份:2018
-
负责人:Lawrence Fong
-
依托单位:
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
-
批准号:10224797
-
项目类别:
-
资助金额:$84.5万
-
财政年份:2018
-
负责人:Lawrence Fong
-
依托单位:
Molecular and immune drivers of immunotherapy responsiveness in prostate cancer
-
批准号:9788321
-
项目类别:
-
资助金额:$84.29万
-
财政年份:2018
-
负责人:Lawrence Fong
-
依托单位:
Immunotherapy of human bladder cancer
-
批准号:9654983
-
项目类别:
-
资助金额:$15.85万
-
财政年份:2015
-
负责人:Lawrence Fong
-
依托单位:
Immunotherapy of human bladder cancer
-
批准号:9104129
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2015
-
负责人:Lawrence Fong
-
依托单位:
Immunotherapy of human bladder cancer
-
批准号:8965456
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2015
-
负责人:Lawrence Fong
-
依托单位:
Immunotherapy of human bladder cancer
-
批准号:9292293
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2015
-
负责人:Lawrence Fong
-
依托单位:
Immunotherapy of human bladder cancer
-
批准号:9514095
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2015
-
负责人:Lawrence Fong
-
依托单位:
Prostatitis and Prostate Cancer Development
-
批准号:8258692
-
项目类别:
-
资助金额:$41.4万
-
财政年份:2012
-
负责人:Lawrence Fong
-
依托单位:
Prostatitis and Prostate Cancer Development
-
批准号:8677581
-
项目类别:
-
资助金额:$40.16万
-
财政年份:2012
-
负责人:Lawrence Fong
-
依托单位:
Prostate Cancer Immunotherapy
-
批准号:8264776
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2009
-
负责人:Lawrence Fong
-
依托单位:
Prostate Cancer Immunotherapy
-
批准号:8449498
-
项目类别:
-
资助金额:$29.23万
-
财政年份:2009
-
负责人:Lawrence Fong
-
依托单位:
Prostate Cancer Immunotherapy
-
批准号:8039216
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2009
-
负责人:Lawrence Fong
-
依托单位:
Prostate Cancer Immunotherapy
-
批准号:7655812
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2009
-
负责人:Lawrence Fong
-
依托单位:
Dendritics Cell Immunotherapy for Colorectal Cancer
-
批准号:7049366
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2004
-
负责人:Lawrence Fong
-
依托单位:
Dendritics Cell Immunotherapy for Colorectal Cancer
-
批准号:7367916
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2004
-
负责人:Lawrence Fong
-
依托单位:
国内基金
海外基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
-
批准号:30840003
-
项目类别:专项基金项目
-
资助金额:12.0万元
-
批准年份:2008
-
负责人:焦宇飞
-
依托单位: